Stigmatised people living with HIV often suffer from fear, depression and abuse. It’s sometimes easier to stop a treatment regime than risk being ostracised or assaulted by the community.
Academic rigor, journalistic flair
Articles on AIDS 2016
Displaying all articles
Taking antiretrovirals is key to reducing HIV infection rates, but the challenge lies in making sure people who know they are infected actually take the drugs.
Mobility is not only a risk factor for HIV – it is also a structural determinant in how HIV responses are designed and implemented.
HIV research continues to search for a cure. The focus is on developing therapies to cure HIV infection or allow people with HIV to safely stop antiretroviral therapy and keep the virus under control.
Three new studies conducted in South Africa provide insights into the engine that drives HIV transmission in the country.
The International AIDS Conference is more than just a talk shop. The platform it offers for engagement between governments, scientists and civil society is of undisputable value.
Top contributors
-
Director, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne and Royal Melbourne Hospital and Consultant Physician, Department of Infectious Diseases, Alfred Hospital and Monash University, The Peter Doherty Institute for Infection and Immunity
-
Clinical Research Fellow, The Peter Doherty Institute for Infection and Immunity
-
Director, Centre for the AIDS Program of Research in South Africa (CAPRISA)
-
Researcher and PhD Candidate at the African Centre for Migration & Society, University of the Witwatersrand
-
Director of the Africa Centre for Population Health and Professor of Virology, University of KwaZulu-Natal
-
Associate professor, University of the Witwatersrand
-
Post-doctoral research fellow, University of KwaZulu-Natal
-
Research Director at The Health Economics and HIV and AIDS Research Division (HEARD), University of KwaZulu-Natal
